FDA warns about feeding tube misconnections

In a letter to manufacturers, healthcare professionals and purchasers, the U.S. Food and Drug Administration (FDA) warned of possible misconnections with enteral devices. The letter states that since 2011, 2 deaths, 24 serious injuries, and 32 device malfunctions related to these misconnections have occurred.
If proper procedure is not followed, these tubes can mistakenly be connected to the wrong medical device and prove fatal. The FDA recommends that healthcare professionals:

Use enteral devices that meet the ISO …

Educate aides about steps they can take to keep patients out of the hospital

Brought to you by Home Health Line.
Aides can be an integral part of preventing hospitalizations, but they are often left out of an agency’s interdisciplinary team.
A new, free online course from the Home Health Quality Improvement (HHQI) National Campaign will help educate aides about how to reduce avoidable hospitalizations.
The one-hour course presents a great opportunity for agencies to engage aides within their scope of practice, says Misty Kevech, RN project coordinator for HHQI.
Course materials were …

Trial of Alzheimer’s drug provides hopeful results

A large clinical trial has, for the first time, shown that a drug can reduce both plaques in the brains of patients with Alzheimer’s disease and slow the progression of their dementia.
According to The New York Times, results presented at the Alzheimer’s Association International Conference in Chicago showed the drug, known currently as BAN2401, actually slowed memory decline and other cognitive difficulties, as well as reduced amyloid levels in brains of affected patients. The trial …

CMS asks Medicare insurance providers to monitor prescriptions of Neudexta

CMS is warning insurance providers to watch prescriptions of Neudexta for off-label use. Neudexta is a prescription meant to treat symptoms of pseudobulbar affect (PBA), which can cause uncontrollable laughter or crying. As CNN reports, prescribing for off-label use is not illegal, but creating a false diagnosis in order to secure coverage of the prescription is fraud.
A CNN investigation last fall indicated that the prescription drug was being given to those without PBA to control …